Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance
M. Yamaguchi, Kiyoshi Takagi, Ai Sato, et al.
Breast Cancer (2020) Vol. 27, Iss. 5, pp. 919-928
Closed Access | Times Cited: 19

Showing 19 citing articles:

Rac1, A Potential Target for Tumor Therapy
Jiaxin Liang, Linda Oyang, Shan Rao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 85
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Daniel J. Turnham, Nicholas Bullock, Manisha S. Dass, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 60
Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells
M. Yamaguchi, Kiyoshi Takagi, Koki Narita, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1918-1918
Open Access | Times Cited: 33
The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages
M. Yamaguchi, Kiyoshi Takagi, Yasuhiro Miki, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1903-1903
Open Access | Times Cited: 11
Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
Ai Sato, Kiyoshi Takagi, M. Yamaguchi, et al.
Experimental and Molecular Pathology (2025) Vol. 141, pp. 104954-104954
Open Access
Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasion
Iku Takahashi, Kiyoshi Takagi, M. Yamaguchi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155379-155379
Open Access | Times Cited: 3
The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance
Claudia C. Wahoski, Bhuminder Singh
Cancers (2024) Vol. 16, Iss. 13, pp. 2472-2472
Open Access | Times Cited: 3
Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors
Pradip De, Brett J. Rozeboom, Jennifer C. Aske, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1541-1541
Open Access | Times Cited: 26
Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
Takashi Sato, Kiyoshi Takagi, Mitsunori Higuchi, et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2022) Vol. 55, Iss. 1, pp. 25-35
Open Access | Times Cited: 14
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
Ai Sato, Kiyoshi Takagi, Ayano Yoshimura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8419-8419
Open Access | Times Cited: 7
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
Alessia Floerchinger, Kendelle J. Murphy, Sharissa L. Latham, et al.
Cell Reports (2021) Vol. 36, Iss. 11, pp. 109689-109689
Open Access | Times Cited: 17
GEFT Inhibits Autophagy and Apoptosis in Rhabdomyosarcoma via Activation of the Rac1/Cdc42-mTOR Signaling Pathway
Chunsen Li, Zhenzhen Li, Lingxie Song, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker
Linglong Tao, Xiaoyu Xu, Zhengxuying Fang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 3, pp. 1533-1553
Open Access | Times Cited: 1
Significance of RCC2, Rac1 and p53 Expression in Breast Infiltrating Ductal Carcinoma; An Immunohistochemical Study
Aiat Shaban Hemida, Reham Abdelaziz, Moshira Mohammed Abd El-Wahed, et al.
Iranian journal of pathology (2024) Vol. 19, Iss. 2, pp. 177-192
Open Access | Times Cited: 1
Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression
M. Yamaguchi, Kiyoshi Takagi, Masayasu Satō, et al.
Oncology Reports (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 9
Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1β upregulation
Angélica Martínez‐López, Ana García‐Casas, Paloma Bragado, et al.
Cancer Letters (2021) Vol. 521, pp. 14-28
Open Access | Times Cited: 7
Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression
Bingbing Liu, Yanning Xu, Lin Zhang, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 5
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
Alessia Floerchinger, Kendelle J. Murphy, Sharissa L. Latham, et al.
(2023)
Open Access | Times Cited: 1
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
Alessia Floerchinger, Kendelle J. Murphy, Sharissa L. Latham, et al.
(2023)
Open Access
Page 1

Scroll to top